Prodex, Inc (NASDAQ: PDEX)
Interview update with Rick Van Kirk, CEO […]
Interview update with Rick Van Kirk, CEO […]
Interview with Rick Van Kirk, CEO […]
Generex Biotechnology Corporation is an integrated healthcare holding company with end‐to‐end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. […]
Interview with COO Bill Abajian […]
Interview with Dwight Egan, CEO […]
MIRAMAR, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (OTCQB:GNBT) today announced that Joe Moscato, the company’s President & Chief Executive Officer conducted an interview with the Wall Street Analyzer, which is available […]
Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan […]
Multi-Center Phase III trial planned for 2019
[…]
“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]
Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a day […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com